Lam Research Corp. director Abhijit Y. Talwalkar reported a change in beneficial ownership of Lam Research common stock tied to a July 13, 2026 transaction involving 18,282 shares at a reported price of $335 per share. The filing states that the transaction was executed under a Rule 10b5-1 trading plan adopted by Talwalkar on March 11, 2026. Such plans allow insiders to schedule trades in advance under predetermined conditions, providing an affirmative defense against claims that trades were made on the basis of material nonpublic information. Based on the reported share count and price, the transaction had an aggregate value of approximately $6.12 million. The document identifies the security as Lam Research common stock. It does not provide, in the text supplied, a visible transaction code such as “S” for open-market sale or “A” for grant/acquisition, nor does it clearly state Talwalkar’s exact beneficial ownership after the transaction. However, the inclusion of a per-share price and the 10b5-1 plan footnote indicate a planned insider trading transaction rather than a routine vesting-only report. A second explanatory note states that the amount reported includes shares subject to unvested restricted stock units. That means the ownership figure reflected in the filing may include equity awards that have not yet fully vested, an important detail when assessing Talwalkar’s continuing economic exposure to Lam Research stock after the reported transaction. The Form 4 was filed July 14, 2026, one day after the July 13 transaction date, and was signed on Talwalkar’s behalf by Marta Woods under power of attorney.